SAHZU Neurologist Prof. LOU Min and her team recently found that, despite an increased risk of symptomatic intracranial hemorrhage, intravenous alteplase provided functional benefit to acute ischemic stroke patients who had salvageable brain tissue but did not undergo initial thrombectomy, when administered 4.5 to 24 hours after stroke onset.
SAHZU President and Academician of Chinese Academy of Sciences Prof. WANG Jian'an and his team are invited to broadcast a complex transcatheter aortic valve replacement (TAVR) procedure live at the SEOUL VALVES 2025 on August 7, 2025.
Two international guidelines spearheaded by Chair of SAHZU Ultrasound Medicine Prof. HUANG Pintong were unanimously approved for development by the International Ultrasound Medicine Alliance Committee.
Prof. WANG Jian'an was invited to Kocaeli University School of Medicine to proctor transcatheter aortic valve replacement (TAVR) procedures using China's self-developed devices, on July 22.
Singer TANK (Lv Jianzhong) from the island of Taiwan, was on the verge of death due to familial hypertrophic cardiomyopathy complicated by liver failure. At the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), he successfully underwent Asia's first simultaneous heart and liver transplantation for familial hypertrophic cardiomyopathy complicated by liver failure and was discharged from the hospital on April 7, 2025.
China's first successful implantation of a closed-loop spinal nerve interface, a breakthrough in neuro-engineering is led by a team of doctors and researchers at the Second Affiliated Hospital of Zhejiang University School of Medicine, Nanhu Brain-computer Interface Institute, Brain-Machine Intelligence Lab, and the College of Biomedical Engineering & Instrument Science.
AI technology is reshaping the healthcare industry at an unprecedented pace. Guided by the core philosophy of "AI services for all," the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) has strategically planned around data elements, exploring the application of AI technology and the upgrading of medical service models to establish an open, collaborative, and win-win panoramic intelligent hospital.
SAHZU recently published on Lancet and introduced a promising alternative to treating coronary artery disease, one of the world's leading causes of heart disease. The study, known as FLAVOUR II, offers fresh insights into improving the way doctors make treatment decisions for patients with coronary artery disease, potentially transforming clinical practice.
In its journey towards becoming a world-class hospital, the Second Affiliated Hospital of Zhejiang University School of Medicine continues to contribute its wisdom and expertise to the global medical community.
The total pancreatectomy with autologous islet transplantation has significantly improved the quality of life of pancreatic cancer patients with better nutrition and a stronger physical condition. This approach can even lead to insulin independence, extend tumor-free survival, reduce surgical complications, and increase the postoperative survival rates, thus laying a solid foundation for prolonging patients’ survival time, and so markedly improving the treatment outcomes for pancreatic cancer surgeries.
SAHZU President and Academician of Chinese Academy of Sciences, Prof. WANG Jian'an was invited to Kocaeli University School of Medicine to proctor transcatheter aortic valve replacement (TAVR) procedures using China's self-developed devices, on July 22.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell1 in March 2024.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).